This site is intended for healthcare professionals
Journals
  • Home
  • /
  • Journals
  • /
  • Allergic reactions
  • /
  • Current status of atopic dermatitis in Japan.
Journal

Current status of atopic dermatitis in Japan.

Read time: 1 mins
Published:1st Jul 2011
Author: <p>Furue M, Chiba T, Takeuchi S.</p>
Availability: Free full text
Ref.:Asia Pac Allergy. 2011 Jul;1(2):64�72.
DOI:10.5415/apallergy.2011.1.2.64

Atopic dermatitis (AD) is a common, chronic or chronically relapsing, severely pruritic, eczematous skin disease. AD is the second most frequently observed skin disease in dermatology clinics in Japan. Prevalence of childhood AD is 12–13% in mainland Japan; however, it is only half that (about 6%) in children from Ishigaki Island, Okinawa. Topical steroids and tacrolimus are the mainstay of treatment. However, the adverse effects and emotional fear of long-term use of topical steroids have induced a "topical steroid phobia" in patients throughout the world. Undertreatment can exacerbate facial/periocular lesions and lead to the development of atopic cataract and retinal detachment due to repeated scratching/rubbing/patting. Overcoming topical steroid phobia is a key issue for the successful treatment of AD through education, understanding and cooperation of patients and their guardians.

 

Read abstract on library site

Access full article